Navigation Links
Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
Date:6/21/2009

clinical developments in the biopharmaceutical industry in general, and with pixantrone in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective (including the failure to achieve the overall response rate, complete remissions and progression-free survival and the possibility of significant grade 3, 4 adverse effects, including cardiac disorders) for the treatment of relapsed, refractory indolent or aggressive NHL as determined by the FDA, the potential that priority review will not be granted by the FDA and that a decision by the FDA is not rendered in six months or in the fourth quarter of 2009, CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    E: media@ctiseattle.com
    www.CellTherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.282.7100
    Lindsey Jesch
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.CellTherapeutics.com/investors

    Medical Information Contact:
    T: 800.715.0944
    E: info@askarm.com


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
4. SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
5. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
6. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
9. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
10. AHF Seeks White House Clarification After Press Room Flap Over CDCs HIV Numbers
11. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015  Agena Bioscience today announced Bioyong Technology as ... platform in China . "The ... a hotbed for practical, meaningful innovations that are improving human ... the rest of the world. We are proud to support ... ," said Peter Dansky , Agena Bioscience,s CEO. ...
(Date:4/27/2015)... , April 27, 2015  As the Innovation ... Philadelphia , InCrowd, provider of on-demand ... assembly of life science insights experts in charting a ... technology and innovation in research. Presented jointly ... supported by Communispace Health, IIeX Health features TED-style presentations ...
(Date:4/27/2015)... HANGZHOU, China , April 27, 2015 ... (the "Company" or " China Jo-Jo "), a leading ... health care products through its online and retail pharmacies, ... Co., Ltd. ("Jiuzhou Pharmacy") has signed a new sales ... wholly owned subsidiary in China ...
Breaking Medicine Technology:Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 2China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 4
... 2007 /PRNewswire-FirstCall/ -,Neurochem (International) Limited (Neurochem), a ... the New England,Journal of Medicine (NEJM) published ... Trial" (EFAAT), recognized as a landmark,clinical trial ... AA amyloidosis. The,results of the Phase II/III ...
... Improves Cognition in two,distinct models of Alzheimer's ... - Prana Biotechnology,Limited (NASDAQ: PRAN / ASX: ... and development of treatments for,neurodegenerative disorders, announced ... Prana's lead Alzheimer's disease (AD) drug PBT2 ...
Cached Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5Prana Biotechnology Presents New Key Findings on PBT2 2Prana Biotechnology Presents New Key Findings on PBT2 3Prana Biotechnology Presents New Key Findings on PBT2 4Prana Biotechnology Presents New Key Findings on PBT2 5
(Date:4/27/2015)... 27, 2015 The Radiology Business ... members with applied business information and intelligence, is proud ... weekly email newsletter for its more than 2,000 members. ... care legislative news sources in that it is exclusively ... business of radiology. The newsletter is produced in cooperation ...
(Date:4/27/2015)... April 27, 2015 Cambia Health ... has joined its team as Operating Partner within ... focused on investing in and building companies that change ... his new role, Albert will be responsible for accelerating ... so that it is both economically sustainable and person-focused, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Health conscious ... have a first-of-its-kind bakery right on their doorstep, which ... for those on restrictive and low-carbohydrate diets. ... grain, and starch free, and will use only natural ... May 1, 2015, strives to provide specialty food that ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... With the FCPX LUT B&W pack from Pixel ... quickly and easily add desaturated color grades to footage. A ... for modifying an image. The LUT changes every pixel's color ... comes with 60 black and white CUBE LUT files. , ... white films. With the FCPX LUT B&W Loader from ...
Breaking Medicine News(10 mins):Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:Cambia Welcomes Ben Albert as Operating Partner 2Health News:Cambia Welcomes Ben Albert as Operating Partner 3Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2
... Security Risks in Exotic Locales , ... Baltimore, MD ... in a down economy should prepare for unexpected medical and security ... vacation. Old and new destinations offering steep discounts may carry risks ...
... kick the habitOLYMPIA, Wash., March 31 A new federal ... cost of a pack of cigarettes by 62 cents. Public ... to quit smoking. The Department of Health,s toll-free Tobacco Quit ... expected loss in sales as more people quit smoking, several ...
... Conference , April 4 - 8 in ChicagoCHICAGO, March 31 ... leading Workforce Management consulting firm, has ... practice dedicated to the Workforce Management (WFM) needs of the ... HIMSS09 , the Healthcare Information and Management ...
... WASHINGTON, March 31 The following is being issued ... 1, at 12:00 noon, D.C. area Pro-life leaders and ... change in HHS regs regarding conscience for health care ... abortion or chemical birth control.A local physician will be ...
... COMPLAINT & ATTORNEY INTERVIEWS AVAILABLE -SEATTLE, March 31 ... tracheal tube clogged with mucous causing oxygen loss and ... Aldercrest Health & Rehabilitation Center in Edmonds, Wash., has ... States-based subsidiaries of Canadian Extendicare REIT. Norene McPherson,s 49-year-old ...
... testimony today before the U.S. Senate Committee on Agriculture, ... revise school food nutrition standards so that more nutritious ... federal nutrition standards for foods sold outside of the ... updated since the late 1970s. , ...
Cached Medicine News:Health News:Don't Sacrifice Your Well-being in a Discount Destination 2Health News:Don't Sacrifice Your Well-being in a Discount Destination 3Health News:Federal Tobacco Tax Increase a Good Reason to Quit Smoking 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 3Health News:Elder Abuse Complaint Filed Against Extendicare 2Health News:Elder Abuse Complaint Filed Against Extendicare 3Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 2Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 3
Small, compact and versatile, the CLK-4 light source is compatible with all Olympus fiberscopes and is ideal for the vast majority of routine fiber-endoscopic procedures, especially in the out-patien...
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers. Polyethylene cover....
Medicine Products: